Skip to main content
Erschienen in: Rheumatology International 2/2012

01.02.2012 | Short Communication

Evaluation of disease activity indices in Korean patients with rheumatoid arthritis

verfasst von: So-Yeon Park, Hyeseon Lee, Soo-Kyung Cho, Chan-Bum Choi, Yoon-Kyoung Sung, Sang-Cheol Bae

Erschienen in: Rheumatology International | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study is to examine the validity of the rheumatoid arthritis (RA), disease activity score (DAS), 28-C-reactive protein (CRP), the simplified disease activity index (SDAI), and the clinical disease activity index (CDAI) against the DAS28-erythrocyte sedimentation rate (ESR) and determine cut-off values for each tool in Korean patients with RA. A total of 223 RA patients were consecutively recruited from the Hanyang University Hospital for Rheumatic Diseases in Seoul, Korea. DAS28-CRP, SDAI, and CDAI were measured and compared with DAS28-ESR. The correlation coefficients of DAS28-ESR with DAS28-CRP, SDAI, and CDAI were 0.93, 0.85, and 0.84, demonstrating strong linear relationships. The cut-off values of DAS28-CRP classifying RA patients into four categories of disease activity were defined as 2.19, 2.60, and 4.07. SDAI cut-off values were defined as 3.75, 7.50, and 16.88. CDAI cut-off values were defined as 3.62, 7.38, and 16.50. DAS28-CRP, SDAI, and CDAI are valid and sensitive assessment indices of disease activity that are comparable to DAS28-ESR. The cut-off values of each tool derived in this study might be useful for routine monitoring and therapeutic decision-making in Korean RA patients.
Literatur
1.
Zurück zum Zitat Van der Heijde DM, Van’t Hof MA, van Riel PL, van de Putte LB (1993) Development of a disease activity score based on judgment in clinical practice by rhematologists. J Rheumatol 20:579–581PubMed Van der Heijde DM, Van’t Hof MA, van Riel PL, van de Putte LB (1993) Development of a disease activity score based on judgment in clinical practice by rhematologists. J Rheumatol 20:579–581PubMed
2.
Zurück zum Zitat Prevoo ML, Van’t Hof MA, Kuper HH, van Leuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef Prevoo ML, Van’t Hof MA, Kuper HH, van Leuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef
3.
Zurück zum Zitat Inoue E, Yamanaka H, Hare M, Tomatsu T, Kamatani N (2007) Comparison of disease activity score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis 66:407–409PubMedCrossRef Inoue E, Yamanaka H, Hare M, Tomatsu T, Kamatani N (2007) Comparison of disease activity score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis 66:407–409PubMedCrossRef
4.
Zurück zum Zitat Matsui T, Kugo Y, Kaneko A, Nishino J, Eto Y, Chiba N et al (2007) Disease activity score 28 (DAS28) using C-reactive protein underestimated disease activity and overestimates EULAR response criteria compare with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 66:1221–1226PubMedCrossRef Matsui T, Kugo Y, Kaneko A, Nishino J, Eto Y, Chiba N et al (2007) Disease activity score 28 (DAS28) using C-reactive protein underestimated disease activity and overestimates EULAR response criteria compare with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis 66:1221–1226PubMedCrossRef
5.
Zurück zum Zitat Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J et al (2009) Validation of the 28-joint disease activity score (DAS28) and European league against rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68:954–960PubMedCrossRef Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J et al (2009) Validation of the 28-joint disease activity score (DAS28) and European league against rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68:954–960PubMedCrossRef
6.
Zurück zum Zitat Castrejon I, Ortiz AM, García-Vicuña R, Lopez-Bote JP, Humbría A, Carmona L et al (2008) Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol 26:769–775PubMed Castrejon I, Ortiz AM, García-Vicuña R, Lopez-Bote JP, Humbría A, Carmona L et al (2008) Are the C-reactive protein values and erythrocyte sedimentation rate equivalent when estimating the 28-joint disease activity score in rheumatoid arthritis? Clin Exp Rheumatol 26:769–775PubMed
7.
Zurück zum Zitat Aletaha D, Smolen JS (2005) The simplified disease activity index and the clinical disease activity index: a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23(5 Suppl 39):100–108 Aletaha D, Smolen JS (2005) The simplified disease activity index and the clinical disease activity index: a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23(5 Suppl 39):100–108
8.
Zurück zum Zitat Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS (2005) Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 52:2625–2636PubMedCrossRef Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS (2005) Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 52:2625–2636PubMedCrossRef
9.
Zurück zum Zitat Bentley MJ, Reed GW (2008) Simplified composite disease activity measure in rheumatoid arthritis; should they be used in standard care? Clin Exp Rheumatol 26:358–366PubMed Bentley MJ, Reed GW (2008) Simplified composite disease activity measure in rheumatoid arthritis; should they be used in standard care? Clin Exp Rheumatol 26:358–366PubMed
11.
Zurück zum Zitat van Leeuwen MA, van Rijswijk MH (1994) Acute phase proteins in the monitoring of inflammatory disorders. Bailliere’s clin Rheumatol 8:531–552CrossRef van Leeuwen MA, van Rijswijk MH (1994) Acute phase proteins in the monitoring of inflammatory disorders. Bailliere’s clin Rheumatol 8:531–552CrossRef
12.
Zurück zum Zitat Ebrel G, Studnicka-Nenke A, Hitzelhammer H, Gschnait F, Smolen JS (2000) Development of a disease activity index for the assessment of reactive arthritis (DAREA). J Rheumatol 39:148–155CrossRef Ebrel G, Studnicka-Nenke A, Hitzelhammer H, Gschnait F, Smolen JS (2000) Development of a disease activity index for the assessment of reactive arthritis (DAREA). J Rheumatol 39:148–155CrossRef
Metadaten
Titel
Evaluation of disease activity indices in Korean patients with rheumatoid arthritis
verfasst von
So-Yeon Park
Hyeseon Lee
Soo-Kyung Cho
Chan-Bum Choi
Yoon-Kyoung Sung
Sang-Cheol Bae
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 2/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-1798-x

Weitere Artikel der Ausgabe 2/2012

Rheumatology International 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.